IXHL Incannex Healthcare Inc.

-

Incannex Healthcare Beat Consensus Estimates

Thursday, November 12, 2026 · 12:00 AM ET

Incannex Healthcare (IXHL) reported a loss of $0.15 per share on revenue of $0.00 million for the fiscal first quarter ended September 2026. The consensus estimate was a loss of $0.66 per share. The company beat consensus estimates by 77.27%.

Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia.

Earnings Whisper Grade —
Power Rating—
Reported Earnings
($0.15)
Earnings Whisper®
—
Consensus Estimate
($0.66)
Earnings Surprise
Earnings Growth-650.0 %
Reported Revenue
—
Revenue Estimate
—
Revenue Surprise
Revenue Growth—